
RakeshVeedu
@rakeshveedu
Founder of SynGenis; Associate Professor & Head of Precision Nucleic Acid Therapeutics Research Group at Murdoch University & Perron Institute, Australia 🇦🇺
ID: 967033760721096705
http://www.rakesh-veedu.com 23-02-2018 13:49:49
98 Tweet
153 Followers
212 Following




Thank you Dr Tracey Wilkinson Caroline Duell Duncan and Team MTPConnect.



I am delighted to share this announcement from the Minister Hon Stephen Dawson MLC. I thank my wonderful team at Murdoch University @cmmit_mu & Perron Institute mediastatements.wa.gov.au/Pages/McGowan/…

💡Dr Liz Dallimore (Argenica Therapeutics), A.Prof RakeshVeedu (SynGenis Pty Ltd), John Barrington AM (Artrya) & Prof. Peter Leedman (miReven P/L) discussed challenges and opportunities as healthcare #innovators. Session chaired by Dr Dr Tracey Wilkinson from @MTPConnect Science on the Swan




Fresh after lunch, the main MCCB session got to hear from RakeshVeedu about new oligonucleotide compounds to treat a number of diseases 🧬💊



Excellent opportunity for another PhD graduate with aptamer development skills to join our team, and be part of an exciting, commercially focused project! Murdoch University @cmmit_mu Perron Institute lnkd.in/gppEgFzj

Murdoch scientists, together with University of Colorado, have developed a new approach to precisely target the genes that cause rare and acquired diseases. This presents a big opportunity to address diseases which disproportionately affect children and adolescents. murdoch.edu.au/news/articles/…


Excited to introduce Thiomorpholinos (TMOs) as a new RNA Therapeutic platform, and share this news article about our recent work published in pnas. Thank you Team at Murdoch University/Perron Institute & the University of Colorado. murdoch.edu.au/news/articles/…

#apaperaday Today’s pick is oligonucleotide themed because the Oligonucleotide Therapeutics Society #OTS22 meeting starts today with an educational session and the next generation session and the welcome reception. The publication is from PNASNews by Le et al from RakeshVeedu group




Associate Professor RakeshVeedu in the spotlight for the recent launch of ProGenis Pharmaceuticals. @cmmit_mu Murdoch University & Perron Institute are all very proud to have been involved with this groundbreaking research into type 2 #diabetes
